Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative safety and efficacy of conventional interferon versus pegylated-interferon based therapy for HCV: A retrospective cohort study from Gujranwala, Pakistan.

Pakistan journal of pharmaceutical sciences - 1 Sept 2020

Iftikhar Usman, Ahmed Mobasher, Saeed Hamid, Saleem Nouman, Bashir Afzaal, Farooq Muhammad Shahid, Kamran Sairah Hafeez, Saleem Zikria

Abstract excerpt

Numerous studies on risk factors, clinical presentation and treatment of hepatitis C are known to the world. However, no data is available about the safety and efficacy of anti-hepatitis C therapy among the patients of Gujranwala, Pakistan. This retrospective study compared two dosage forms of interferon; conventional interferon (IR) and Pegylated interferon (PIR) in 370 Hepatitis C patients selected through non...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Pakistan

Share to Polyethylene Glycols

Share to Ribavirin

Share to Sustained Virologic Response

Source

Identifiers

PMID: 33824111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative safety and efficacy of conventional interferon versus pegylated-interferon based therapy for HCV: A retrospective cohort study from Gujranwala, Pakistan.PMID 33824111Read ↗

Time for change: conventional interferon regimes should not be the standard of care for management of Pakistani genotype-3 in chronic hepatitis C.Semantic proximity Read ↗

Effect of Pegylated-interferon (Peg-inf) Plus Ribavirin (Rbv) Therapy on Haematological Profile of Different Age Groups Infected by Hepatitis C Virus in PakistanSemantic proximity Read ↗

Hepatitis C Virus and Interferon-Free Antiviral Therapeutics Revolution: Implications for Pakistan.Semantic proximity Read ↗

Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.Semantic proximity Read ↗

Treatment outcome in chronic hepatitis C infection: a four years survey among Iranian patients.Semantic proximity Read ↗

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.Semantic proximity Read ↗

Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan.Semantic proximity Read ↗

Diagnosis, Management And Prevention Of Hepatitis C In Pakistan 2017.Semantic proximity Read ↗

Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals .Semantic proximity Read ↗

Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a Brazilian sample.Semantic proximity Read ↗

Prevalence of hepatitis-C virus genotypes and potential transmission risks in Malakand Khyber Pakhtunkhwa, Pakistan.Semantic proximity Read ↗

An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.